Verrica Pharmaceuticals (VRCA) Q4 2022 Earnings

6MarConfirmed
May 22
Aug 22
Nov 22
Q4 2022
-0.47
-0.31
-0.16
0

Details

Expected EPS
-0.19
Actual EPS
-0.14
Surprise EPS
0.05
Surprise Percent
+26.32%

Description

Verrica Pharmaceuticals (VRCA) has reported earnings of -0.14 per share for Q4 2022.

0 Comments

Share your thoughts